Early cardiac derisking: A clinically translatable hiPSC cardiomyocyte assay
Achieve action potential recordings from intrinsically paced hiPSC-CMs with Metrion’s clinically predictive hiPSC cardiomyocyte assay.
- Simultaneous high-resolution measurement across 96 well plate at 10,000 Hz
- Recordings using voltage-sensitive dye equivalent in quality to patch clamp
- Multiple endpoints evaluated (APD20/50/90, rise time, beat rate, triangulation)
- Measurement of acute (30min) and chronic (24h/48h) effects
- Predicts clinical exposure associated with 10ms QTc prolongation
- Defines exposure associated with QRS probability
- Highlights unknown acute/chronic toxicity
Read more about our hiPSC cardiomyocyte assay.
Contact us for a quote or discussion